Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Association of macular disease with long-term use of pentosan polysulfate sodium: findings from a US cohort.

Jain N, Li AL, Yu Y, VanderBeek BL.

Br J Ophthalmol. 2019 Nov 6. pii: bjophthalmol-2019-314765. doi: 10.1136/bjophthalmol-2019-314765. [Epub ahead of print]

PMID:
31694837
2.

Anaemia and the risk of progression from non-proliferative diabetic retinopathy to vision threatening diabetic retinopathy.

Li Y, Yu Y, VanderBeek BL.

Eye (Lond). 2019 Oct 4. doi: 10.1038/s41433-019-0617-6. [Epub ahead of print]

PMID:
31586167
3.

Association of Opioids With Incisional Ocular Surgery.

Kolomeyer AM, Yu Y, VanderBeek BL.

JAMA Ophthalmol. 2019 Sep 19. doi: 10.1001/jamaophthalmol.2019.3694. [Epub ahead of print]

PMID:
31536096
4.

Determinants in Initial Treatment Choice for Diabetic Macular Edema.

VanderBeek BL, Scavelli K, Yu Y.

Ophthalmol Retina. 2019 May 25. pii: S2468-6530(19)30197-6. doi: 10.1016/j.oret.2019.05.016. [Epub ahead of print]

PMID:
31345726
5.

Repeated intravitreal injections of antivascular endothelial growth factors and risk of intraocular pressure medication use.

Cui QN, Gray IN, Yu Y, VanderBeek BL.

Graefes Arch Clin Exp Ophthalmol. 2019 Sep;257(9):1931-1939. doi: 10.1007/s00417-019-04362-7. Epub 2019 May 31.

PMID:
31152311
6.

Adherence to Clinical Trial Supported Evaluation of Optic Neuritis.

Meer E, Shindler KS, Yu Y, VanderBeek BL.

Ophthalmic Epidemiol. 2019 Oct;26(5):321-328. doi: 10.1080/09286586.2019.1621352. Epub 2019 May 29.

PMID:
31140885
7.

Blindness and Visual Impairment in the Medicare Population: Disparities and Association with Hip Fracture and Neuropsychiatric Outcomes.

Hamedani AG, VanderBeek BL, Willis AW.

Ophthalmic Epidemiol. 2019 Aug;26(4):279-285. doi: 10.1080/09286586.2019.1611879. Epub 2019 May 7.

PMID:
31062638
8.

Predictive factors for patients receiving intravitreal anti-vascular endothelial growth factor for the treatment of diabetic macular edema.

Carroll RM, Yu Y, VanderBeek BL.

Eur J Ophthalmol. 2019 Feb 14:1120672119827856. doi: 10.1177/1120672119827856. [Epub ahead of print]

PMID:
30764665
9.

The Argument for Sterile Loading of All Intravitreal Injections and the Benefit of Replicated Results.

VanderBeek BL.

JAMA Ophthalmol. 2019 Apr 1;137(4):343-344. doi: 10.1001/jamaophthalmol.2018.7089. No abstract available.

PMID:
30763431
10.

Techniques for improving ophthalmic studies performed on administrative databases.

Borkar DS, Sobrin L, Hubbard RA, Kempen JH, VanderBeek BL.

Ophthalmic Epidemiol. 2019 Jun;26(3):147-149. doi: 10.1080/09286586.2018.1554160. Epub 2018 Dec 6. No abstract available.

PMID:
30521404
11.

COMPARATIVE RISK OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION WITH BEVACIZUMAB, AFLIBERCEPT, AND RANIBIZUMAB.

Bavinger JC, Yu Y, VanderBeek BL.

Retina. 2019 Oct;39(10):2004-2011. doi: 10.1097/IAE.0000000000002351.

PMID:
30312260
12.

Comparative Effectiveness of Generic Latanoprost Versus Branded Prostaglandin Analogs for Primary Open Angle Glaucoma.

Kim DH, Addis VM, Pan W, VanderBeek BL.

Ophthalmic Epidemiol. 2019 Feb;26(1):63-71. doi: 10.1080/09286586.2018.1516786. Epub 2018 Sep 6.

PMID:
30188773
13.

Automated segmentation of the choroid in EDI-OCT images with retinal pathology using convolution neural networks.

Chen M, Wang J, Oguz I, VanderBeek BL, Gee JC.

Fetal Infant Ophthalmic Med Image Anal (2017). 2017 Sep;10554:177-184. Epub 2017 Sep 9.

14.

Association of Hypovitaminosis D With Increased Risk of Uveitis in a Large Health Care Claims Database.

Sobrin L, Stanwyck LK, Pan W, Hubbard RA, Kempen JH, VanderBeek BL.

JAMA Ophthalmol. 2018 May 1;136(5):548-552. doi: 10.1001/jamaophthalmol.2018.0642.

15.

SYSTEMIC BETA-BLOCKERS AND RISK OF PROGRESSION TO NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.

Kolomeyer AM, Maguire MG, Pan W, VanderBeek BL.

Retina. 2019 May;39(5):918-925. doi: 10.1097/IAE.0000000000002059.

PMID:
29394237
16.

Association of Novel Oral Antithrombotics With the Risk of Intraocular Bleeding.

Uyhazi KE, Miano T, Pan W, VanderBeek BL.

JAMA Ophthalmol. 2018 Feb 1;136(2):122-130. doi: 10.1001/jamaophthalmol.2017.5677.

17.

Revision Surgery After Dacryocystorhinostomy in a National Cohort.

Eftekhari K, Kozin ED, VanderBeek BL.

JAMA Ophthalmol. 2018 Jan 1;136(1):94-95. doi: 10.1001/jamaophthalmol.2017.4881. No abstract available.

18.

TESTOSTERONE SUPPLEMENTATION AND RETINAL VASCULAR DISEASE.

Dedania VS, Zacks DN, Pan W, VanderBeek BL.

Retina. 2018 Nov;38(11):2247-2252. doi: 10.1097/IAE.0000000000001869.

19.

Re: Yeung et al.: β-blockers and neovascular age-related macular degeneration (Ophthalmology. 2017;124:409-411).

Kolomeyer AM, Traband A, VanderBeek BL.

Ophthalmology. 2017 Sep;124(9):e70-e71. doi: 10.1016/j.ophtha.2017.03.063. No abstract available.

PMID:
28823357
20.

Erratum. Diabetic Retinopathy: A Position Statement by the American Diabetes Association. Diabetes Care 2017;40:412-418.

Solomon SD, Chew E, Duh EJ, Sobrin L, Sun JK, VanderBeek BL, Wykoff CC, Gardner TW.

Diabetes Care. 2017 Sep;40(9):1285. doi: 10.2337/dc17-er09. Epub 2017 Jul 13. No abstract available.

21.

Accuracy of Billing Codes Used in the Therapeutic Care of Diabetic Retinopathy.

Lau M, Prenner JL, Brucker AJ, VanderBeek BL.

JAMA Ophthalmol. 2017 Jul 1;135(7):791-794. doi: 10.1001/jamaophthalmol.2017.1595.

22.

Erratum. Diabetic Retinopathy: A Position Statement by the American Diabetes Association. Diabetes Care 2017;40:412-418.

Solomon SD, Chew E, Duh EJ, Sobrin L, Sun JK, VanderBeek BL, Wykoff CC, Gardner TW.

Diabetes Care. 2017 Jun;40(6):809. doi: 10.2337/dc17-er06e. Epub 2017 Apr 21. No abstract available.

23.

Reply.

Parikh RN, Traband A, Kolomeyer AM, VanderBeek BL, Kim BJ, Maguire AM, Brucker AJ.

Am J Ophthalmol. 2017 May;177:229. doi: 10.1016/j.ajo.2017.02.008. Epub 2017 Mar 18. No abstract available.

PMID:
28325547
24.

Diabetic Retinopathy: A Position Statement by the American Diabetes Association.

Solomon SD, Chew E, Duh EJ, Sobrin L, Sun JK, VanderBeek BL, Wykoff CC, Gardner TW.

Diabetes Care. 2017 Mar;40(3):412-418. doi: 10.2337/dc16-2641. Review. No abstract available. Erratum in: Diabetes Care. 2017 Jun;40(6):809. Diabetes Care. 2017 Jul 13;:.

25.

Intravitreal Bevacizumab for the Treatment of Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy.

Parikh RN, Traband A, Kolomeyer AM, VanderBeek BL, Kim BJ, Maguire AM, Brucker AJ.

Am J Ophthalmol. 2017 Apr;176:194-202. doi: 10.1016/j.ajo.2017.01.010. Epub 2017 Jan 24.

26.

Trends in Corneal Transplantation in Keratoconus.

Sarezky D, Orlin SE, Pan W, VanderBeek BL.

Cornea. 2017 Feb;36(2):131-137. doi: 10.1097/ICO.0000000000001083.

27.

Retinal Prostheses in the Medicare Population [Internet].

Fontanarosa J, Treadwell JR, Samson DJ, VanderBeek BL, Schoelles K.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Sep 30.

28.

SYSTEMIC BETA-BLOCKERS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.

Traband A, Shaffer JA, VanderBeek BL.

Retina. 2017 Jan;37(1):41-46. doi: 10.1097/IAE.0000000000001226.

29.

Oral Fluoroquinolones, Retinal Detachments, and Claims Database Studies.

VanderBeek BL.

JAMA Ophthalmol. 2016 Apr;134(4):422-3. doi: 10.1001/jamaophthalmol.2016.0240. No abstract available.

30.

Trends in the Care of Diabetic Macular Edema: Analysis of a National Cohort.

VanderBeek BL, Shah N, Parikh PC, Ma L.

PLoS One. 2016 Feb 24;11(2):e0149450. doi: 10.1371/journal.pone.0149450. eCollection 2016.

31.

Oral Fluoroquinolones and the Risk of Uveitis.

Sandhu HS, Brucker AJ, Ma L, VanderBeek BL.

JAMA Ophthalmol. 2016 Jan;134(1):38-43. doi: 10.1001/jamaophthalmol.2015.4092.

32.

The Association between Intravitreal Steroids and Post-Injection Endophthalmitis Rates.

VanderBeek BL, Bonaffini SG, Ma L.

Ophthalmology. 2015 Nov;122(11):2311-2315.e1. doi: 10.1016/j.ophtha.2015.07.005. Epub 2015 Aug 15.

33.

Association of compounded bevacizumab with postinjection endophthalmitis.

VanderBeek BL, Bonaffini SG, Ma L.

JAMA Ophthalmol. 2015 Oct;133(10):1159-64. doi: 10.1001/jamaophthalmol.2015.2556.

34.

Re: Changing Trends in the Management of Diabetic Macular Edema at a Single Institution Over the Past Decade.

VanderBeek BL.

Retina. 2015 Jul;35(7):e40-2. doi: 10.1097/IAE.0000000000000670. No abstract available.

35.

Outcomes, impact on management, and costs of fungal eye disease consults in a tertiary care setting.

Ghodasra DH, Eftekhari K, Shah AR, VanderBeek BL.

Ophthalmology. 2014 Dec;121(12):2334-9. doi: 10.1016/j.ophtha.2014.06.042. Epub 2014 Aug 10.

36.

Additional considerations in the utility of dark adaptometry for the diagnosis of age-related macular degeneration.

VanderBeek BL.

Invest Ophthalmol Vis Sci. 2014 May 19;55(5):3148. doi: 10.1167/iovs.14-14317. No abstract available.

PMID:
24840310
37.

Risk of retinal tear or detachment with oral fluoroquinolone use: a cohort study.

Eftekhari K, Ghodasra DH, Haynes K, Chen J, Kempen JH, VanderBeek BL.

Pharmacoepidemiol Drug Saf. 2014 Jul;23(7):745-52. doi: 10.1002/pds.3623. Epub 2014 Apr 22.

38.

Volume and composition of reflux after intravitreal injection.

Brodie FL, Ruggiero J, Ghodasra DH, Hui JZ, VanderBeek BL, Brucker AJ.

Retina. 2014 Jul;34(7):1473-6. doi: 10.1097/IAE.0000000000000098.

39.

A novel method for the measurement of reflux from intravitreal injections: data from 20 porcine eyes.

Brodie FL, Ruggiero J, Ghodasra DH, Eftekhari K, Hui JZ, Brucker AJ, VanderBeek BL.

Curr Eye Res. 2014 Jul;39(7):752-7. doi: 10.3109/02713683.2013.864774. Epub 2013 Nov 20.

40.

Role of statins in the development and progression of age-related macular degeneration.

VanderBeek BL, Zacks DN, Talwar N, Nan B, Stein JD.

Retina. 2013 Feb;33(2):414-22. doi: 10.1097/IAE.0b013e318276e0cf.

41.

Change in choroidal thickness after chemotherapy in leukemic choroidopathy.

Bajenova NV, Vanderbeek BL, Johnson MW.

Retina. 2012 Jan;32(1):203-5. doi: 10.1097/IAE.0b013e31822b1f68. No abstract available.

PMID:
22105507
42.

The diversity of traction mechanisms in myopic traction maculopathy.

VanderBeek BL, Johnson MW.

Am J Ophthalmol. 2012 Jan;153(1):93-102. doi: 10.1016/j.ajo.2011.06.016. Epub 2011 Sep 9.

PMID:
21907964
43.

Rates of nonexudative and exudative age-related macular degeneration among Asian American ethnic groups.

Stein JD, Vanderbeek BL, Talwar N, Nan B, Musch DC, Zacks DN.

Invest Ophthalmol Vis Sci. 2011 Aug 29;52(9):6842-8. doi: 10.1167/iovs.11-7179.

44.

Racial differences in age-related macular degeneration rates in the United States: a longitudinal analysis of a managed care network.

Vanderbeek BL, Zacks DN, Talwar N, Nan B, Musch DC, Stein JD.

Am J Ophthalmol. 2011 Aug;152(2):273-282.e3. doi: 10.1016/j.ajo.2011.02.004. Epub 2011 Jun 22.

45.

Comparing the detection and agreement of parapapillary atrophy progression using digital optic disk photographs and alternation flicker.

VanderBeek BL, Smith SD, Radcliffe NM.

Graefes Arch Clin Exp Ophthalmol. 2010 Sep;248(9):1313-7. doi: 10.1007/s00417-010-1376-z.

PMID:
20393740
46.
47.

The use of conscious sedation for pain control during forearm fracture reduction in children: does race matter?

VanderBeek BL, Mehlman CT, Foad SL, Wall EJ, Crawford AH.

J Pediatr Orthop. 2006 Jan-Feb;26(1):53-7.

PMID:
16439902
48.

Dexamethasone exposure during the neonatal period alters ORL1 mRNA expression in the hypothalamic paraventricular nucleus and hippocampus of the adult rat.

Neal CR Jr, VanderBeek BL, Vázquez DM, Watson SJ Jr.

Brain Res Dev Brain Res. 2003 Dec 19;146(1-2):15-24.

PMID:
14643007

Supplemental Content

Loading ...
Support Center